KYMERA THERAPEUTICS INC's ticker is KYMR and the CUSIP is 501575104. A total of 128 filers reported holding KYMERA THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $46,674,590 | -37.1% | 3,357,884 | +4.1% | 0.00% | -50.0% |
| Q2 2023 | $74,162,199 | -24.8% | 3,225,846 | -3.1% | 0.00% | -33.3% |
| Q1 2023 | $98,673,530 | +18.5% | 3,330,190 | -0.1% | 0.00% | 0.0% |
| Q4 2022 | $83,239,129 | +19.3% | 3,334,901 | +4.1% | 0.00% | +50.0% |
| Q3 2022 | $69,767,000 | +25.3% | 3,204,682 | +13.3% | 0.00% | 0.0% |
| Q2 2022 | $55,691,000 | -61.5% | 2,828,434 | -17.3% | 0.00% | -50.0% |
| Q1 2022 | $144,698,000 | -32.9% | 3,419,084 | +0.6% | 0.00% | -20.0% |
| Q4 2021 | $215,709,000 | +20.8% | 3,397,540 | +11.7% | 0.01% | 0.0% |
| Q3 2021 | $178,595,000 | +50.4% | 3,040,431 | +24.2% | 0.01% | +66.7% |
| Q2 2021 | $118,754,000 | +101.9% | 2,448,517 | +61.7% | 0.00% | +50.0% |
| Q1 2021 | $58,831,000 | -33.0% | 1,513,923 | +6.9% | 0.00% | -33.3% |
| Q4 2020 | $87,832,000 | +254.6% | 1,416,631 | +84.8% | 0.00% | +200.0% |
| Q3 2020 | $24,769,000 | – | 766,594 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| AJU IB Investment Co., Ltd. | 457,059 | $9,950,000 | 17.03% |
| Atlas Venture Life Science Advisors, LLC | 6,875,698 | $149,684,000 | 16.52% |
| BVF INC/IL | 4,692,604 | $102,158,000 | 4.22% |
| Aquilo Capital Management, LLC | 330,246 | $7,189,000 | 2.59% |
| Redmile Group, LLC | 2,876,637 | $62,624,000 | 2.43% |
| Artal Group S.A. | 1,500,000 | $32,655,000 | 1.39% |
| Deer Management Co. LLC | 615,895 | $13,408,000 | 0.94% |
| Avoro Capital Advisors LLC | 2,169,230 | $47,224,000 | 0.87% |
| AtonRa Partners | 34,462 | $750,000 | 0.74% |
| Rock Springs Capital Management LP | 1,046,743 | $22,788,000 | 0.59% |